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EUiott (1) described an extraceUular proteolytic enzyme, streptococcal pro- 
teinase, in broth cultures of certain strains of group A streptococci grown under 
favorable  cultural  conditions.  He  observed  that  this  enzyme digested  the 
type-specific M protein antigen of group A streptococci as well as streptokinase, 
fibrin, milk,  and casein.  This enzyme was active under reducing conditions 
of bacterial  growth;  and  in  cell-free systems  it  was  activated  by cysteine, 
glutathione, potassium cyanide, and thioglycollie acid but was inactivated by 
iodoacetic acid  and  by  normal  mouse  or  rabbit  serum.  In  a  later  report 
Elliott and Dole (2) found that the yield of active proteinase was greatest in 
broth  containing undialyzed Pfanstiehl peptone and  that  cultures grown in 
media prepared with the dialysate of Pfanstiehl peptone or with undialyzed 
neopeptone produced the inactive precursor of streptococcal proteinase. 
Todd (3) also demonstrated a  streptococcal enzyme in culture filtrates of 
many strains of group A  streptococci and found it to be antigenic.  It was 
considered probably identical with the one described by Elliott. 
It seemed important to  determine the possible relationship  of this newly 
discovered enzyme to  the pathogenesis of streptococcal infections and  their 
sequelae.  A study was therefore undertaken to determine whether proteinase 
production by hemolytic streptococci isolated from patients with streptococcal 
infections as well as those isolated from normal carriers was in any way cor- 
related  with  different  types  of  clinical  response.  The  capacity  of  various 
serological groups and types of hemolytic streptococci to elaborate proteinase 
was also investigated; and a  study was made of the presence of proteinase as 
related to the presence of streptokinase in broth cultures of group A strepto- 
cocci. 
Materials  and  Methods 
Source of Streptococcal Strains.raThe majority of the strains were isolated at the Hospital 
of The Rockefeller  Institute  for Medical Research in 1940-47 from pharyngeal cultures of 
rheumatic and non-rheumatic subjects suffering  from pharyngitis-,  scarlet fever, or rheumatic 
fever, or from throat cultures of normal carriers.  Many of the patients developed purulent 
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complications such  as  sinusitis,  otitis  media,  peritonsillar abscess,  cervical lymphadenitisj 
pneumonia, or impetigo; others developed rheumatic fever following their streptococcal infec- 
tions.  In a few instances both purulent complications and rheumatic fever were observed in 
the  same patients.  The  cartier  strains  were  cultured  from  rheumatic  subjects  and  their 
siblings who developed no clinical evidence of disease and no streptococcal antibody response. 
Other strains were isolated in the Chicago area at the Great Lakes Naval Training Station 
during the spring of 1946 from pharyngeal cultures of patients with streptococcal respiratory 
diseases including scarlet fever, some of whom later developed rheumatic fever.  All these 
strains were frozen and dried shortly after isolation from the patients and kept in this state 
until used.  A few lyophiliz~d streptococcal strains were selected from laboratory stock cul- 
tures to complete the series  of all the known serological groups and types; these strains had 
probably in many instances been subcultured numerous times before lyophilization. 
Grouping and Typing of Streptococcal Strains.--The hemolytic streptococci were classified 
into  serological  groups and  types by the precipitin  technique  (4,  5).  In a  few instances, 
strains which could not be classified  by the precipitin method with the available sera were 
tested by cross-agglutination with homologous and heterologous rabbit antlsexa to determine 
whether they were antigenically similar or dissimilar. 
Preparation of Cultures.--Each strain was seeded from the lyophilized stock of cultures 
into 5 cc. of Todd-Hewitt broth containing 2 per cent Pfanstiehl peptone or 1 per cent neopep- 
tone and incubated in a water bath at 37°C. for 12 hours.  A loopful of the actively growing 
culture was then transferred to 5 cc. of fresh broth and incubated for 28 hours at 37°C. 
Determination of Proteinase Activity.--Pfanstlehl peptone  broth was  used exclusively to 
prepare cultures for determinations of proteinase activity unless otherwise stated.  A method, 
described by Elliott and Dole (2), which employs the coagulation of a milk-thioglycollate mix- 
ture was used in most experiments.  Preliminary studies revealed that whole broth cultures 
gave results for proteinase assay comparable to  those  obtained with filtrates  or supernates 
of  these  cultures.  Because  of  simplicity, whole  broth  cultures  were  therefore  employed. 
Control cultures were included in each series of tests, namely, a positive strain (K43)  and a 
negative strain (K43 mouse passage). 
In a few experiments the "azocoll" digestion technique (3) was carried out in parallel with 
the milk-thioglycollate method to estimate proteinase activity of streptococcal cultures. 
Estimation of Streptokinase.--The method  employed for the estimation of streptokinase 
was a modification of that described by Tillett, Edwards, and  Garner (6) and the  Commission 
on Acute Respiratory Diseases (7). 
The cultures of streptococci prepared for proteinase determination were tested for strep- 
tokinase by mixing gently 1.0 cc. of filtrate with 1.0 cc. of 0.6 per cent solution of a lyophil~ed 
fibrinogen,  fraction  I  (Cohn) 1,  from human  plasma  in  physiological saline,  buffered with 
veronal at pH 7.5 and 0.2 cc. of bovine thrombin in a  1 : 10 dilution of the same buffer.  The 
mixtures were incubated in a water bath at 37°C.  The streptokinase activity of the various 
strains was determined by liquefaction of the standard  fibrin clot.  Liquefaction was con- 
sidered to have taken place when the clot moved or flowed freely on inversion of the tube. 
OBSERVATIONS  AND RESULTS 
Proteinase Capacity of Group  A  Streptococci  in Relation to the Clinical Re- 
sponse.rathe proteinase-producing  capacity of strains of group A  streptococci 
isolated from patients with various clinical responses to streptococcal infection 
and  from  the  throats  of normal  carriers  is  summarized  in  Table  I.  Of  155 
1 Fibrinogen human fraction I was obtained through the courtesy of Sharp and Dohme. SIDNEY  ROTHBARD  AND  EDGAR  W.  TODD  285 
strains cultured from  144  patients or carriers  between October,  1940, and 
April, 1947, 70 produced proteinase and 85 did not produce any of this enzyme. 
At different times 8 patients suffered more than one streptococcal  infection. 
These  were considered separate infections because  the same serological type 
was not observed  in the recurrent infections,  and because significant rises in 
the antistreptolysin O titre of the patients' sera occurred.  In the case of car- 
riers, observations were confined to a single strain from each individual unless 
a  change  in  serological  type was  observed.  All streptococcal  strains were 
isolated from nasopharyngeal cultures within 5 days after the onset of infection 
with the exception of those from 9 patients with a primary attck of rheumatic 
fever from whom cultures were not obtained until 2 to 4 weeks after infection. 
Seventy-three of the strains included in Table I  were isolated from patients 
with scarlet fever.  These are not grouped separately because the only differ- 
ence between the patients with scarlet fever and those with pharyngitis alone 
was the erythematous rash. 
Of 47 group A streptococcal  strains cultured from patients who made un- 
eventful recoveries from their acute pharyngitis, 25 strains produced proteinase 
and 22 failed to elaborate this enzyme.  From patients with purulent compli- 
cations, 15 group A streptococcal strains were isolated and all except one strain 
failed to produce proteinase.  Ten of the 14 strains which did not elaborate 
the enzyme, however, were all serological type 19 and were isolated from the 
same epidemic.  Apparently these strains were derived from a common source. 
Among 34 strains isolated from patients who developed  a primary attack of 
acute rheumatic fever, 15 produced proteinase and 19 did not.  In this group, 
3 strains were cultured from patients who developed both purulent complica- 
tions and rheumatic fever. 
In Table I are also recorded the results of the proteinase capacity of a series 
of strains isolated from the nasopharynges of rheumatic subjects who suffered 
hemolytic  streptococcal  infections  of  the  upper  respiractory  tract.  The 
strains from those patients who developed a recurrence of rheumatic fever can 
be contrasted with strains isolated from patients who did not develop  rheu- 
matic fever following the streptococcal  infection.  Of 19 strains, each isolated 
from a different infection followed by an attack of rheumatic fever, 9 produced 
proteinase and 10 did not.  Among the patients who did not develop  rheu- 
matic fever, there were 23 infections.  Ten strains from these infections pro- 
duced proteinase and 13 failed to show any activity. 
One instance is of interest because the same strain, producing proteinase in 
~itro, induced different clinical reactions in susceptible rheumatic subjects.  A 
group A streptococcus  of an unclassified type was cultured from a rheumatic 
subject with an attack of acute pharyngitis that was not followed by rheumatic 
fever; this same type caused  an accidental respiratory infection in another 
rheumatic susceptible  subject, who subsequently developed  rheumatic fever. 286  PRODUCTION  O1  ¢  PROTEINASE  BY HEMOLYTIC  STREPTOCOCCI 
The streptococci from these patients were shown to be the same type by cross- 
agglutination tests with homologous and heterologous rabbit antisera. 
The proteinase  capacity of streptococcal strains  cultured  from the  throats 
of  subjects  who  developed  no  apparent  infection  is  also  shown  in  Table  I. 
These individuals were observed at 3 to 4 week intervals for several years, and 
no clinical or laboratory evidence of infection appeared when these strains were 
isolated.  Moreover, no elevated titres for antistreptolysin  0, antifibrinolysin 
and, in a few cases studied, bacteriostatic antibodies were observed in the sera 
TABLE I 
Proteinase Production by Group A Streptococci as Related  to Clinical Response 
to Streptococcal Infection 
Clinical response  to streptococcal  infection 
Pharyngitis:  Uncomplicated .............................. 
"  With purulent complications .................. 
"  Followed by primary attack of rheumatic 
fever ..................................... 
"  Followed by recurrence of rheumatic fever in 
rheumatic  subjects ......................... 
"  Followed by no recurrence of rheumatic fever 
in rheumatic subjects ....................... 
No infection:  Normal carriers .............................. 
Total .................................................  , 
Proteinase  production by 
streptococci  isolated  from 
individual patients 
No. of strains 
Positive  Negative 
25  22 
1  14" 
15  19 
9  10 
10  13 
10  7 
70  85 
* Ten of these strains were isolated from the same epidemic and were of the same serological 
type. 
of these subjects.  Of 17 strains from these individuals,  10 strains had demon- 
strable proteinase activity but 7 were proteinase-negative. 
Upon consideration of the data presented in this table, there appears to be no 
evidence that proteinase- or non-proteinase-producing  strains  were associated 
with any particular variety of streptococcal infectious process:  Strains with or 
without  proteinase  activity were each  isolated from normal  carriers  or from 
patients who developed rheumatic fever, purulent processes, or uncomplicated 
infections. 
Proteinase Production of Epidemic, Endemic, and Carrier Strains of Group A 
Streptococci.--An  opportunity  presented  itself  to  investigate  the  proteinase 
capacity of epidemic,  endemic, and carrier strains of various serological types 
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Naval personnel in  New York  City from 1942-44 and  in  the  Chicago area 
during 1945.  The endemic and carrier strains were obtained during 194(}-47 
from children and young adults in New York City who were in no contact with 
those from whom the epidemic strains were cultured.  In Table II is shown the 
proteinase production of these 3  groups of strains.  A  variety of serological 
types are represented in each group and  the time of isolation is spread over 
relatively similar dates.  Twelve of the endemic and 11 of the carrier strains 
could not be typed by the precipitin method with the available sera, and are 
therefore not included in the number of serological types but are included in the 
number of strains investigated. 
It is apparent from the results shown in Table II that irrespective of whether 
the streptococci are of epidemic, endemic, or carrier source, there is approxi- 
TABLE II 
Protelnase  Production  of Group A  Streptococci as Related to Their Sources: 
Epidemic, Endemic, and Carrier Strains 
Source of streptococci 
Epidemic  ....... 
Endemic. 
Carrier  ......... 
No. of strsins 
91 
47*  "1 
,  17" 
No. of serolog- 
ical types 
16 
18 
5 
Pmteinue production by 
indDidusl strains 
Positive  Negative 
37  54 
24  23 
10  7 
*Twelve of the endemic and 11 of the carrier strains could not be typed with available 
sera;  the number of types represented by the remainder is indicated in the third colnm,,, 
mately  an  equal  distribution  of  proteinase-  and  non-proteinase-producing 
strains.  Moreover, it can be seen that  16  different serological types are in- 
cluded in the epidemic group.  If, on the other hand, a single serological type 
from an epidemic and, presumably,  from a  common source is assayed, a uni- 
form pattern of proteinase production will be observed.  Examples of this will 
be presented in Table III. 
Lack of Correlation between  Proteinase Capacity of Serological Types of Group A 
Streptococci and Clinical Manifestations.--To  ascertain whether there is  any 
correlation between the proteinase activity of strains belonging to a single type 
and the clinical reaction to infections induced by these strains, numerous sero- 
logical types of streptococci were studied.  In Table III are presented 5 repre- 
sentative  examples  to illustrate  the proteiuase production of strains  of  the 
same serological type cultured from patients whose clinical response to  strep- 
tococcal infections varied.  It can be seen that the serological types 1, 3, and 19 
comprise both proteinase- and non-proteinase-produCing strains; and in  these 
types, strains of the same serological type and proteinase activity frequently 
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the  type 30  strains  all  of  which,  isolated from a  single  epidemic,  produced 
proteolytic enzyme.  In contrast to this, most of the type 17 strains,  chiefly 
from the  same epidemic, did  not produce proteinase but  were,  nevertheless, 
able to initiate a variety of clinical effects. 
On the other hand, as exemplified in type 19 (Table III), strains of the same 
serological type but differing in their ability to produce proteinase, were often 
found  to  give  rise  to  the  same  clinical  manifestations  in  different  patients. 
Similar results were obtained with  17 other serological types not recorded  in 
TABLE  III 
LAck of Correlation between Proteinase Production by Group A Streptococci of Various 
Serological Types and Clinical Response to Infection 
Clinical response to streptococcal infection 
Pharyngitis:  Uncomplicated  .................... 
"  With purulent complications  ........ 
"  Followed  by primary attack of 
rheumatic fever .................. 
*.'  Followed by  recurrence  of  rheumatic 
fever in rheumatic subjects ........ 
"  Followed  by  no recurrence  of rheumatic 
fever in rheumatic subjects ........ 
No infection: Normal carriers .................... 
Totals .........  : ............................ 
Proteinase production  by individual strains  of 
streptococci  of  various  serological  types 
isolated  from  patients  with  different  clinical 
responses  to  infection 
Type 1 
1 
1 
1 
2 
2  3 
Tyle 3 
3 
1 
2 
1 
4  3 
Ty] e  17 
3 
2 
1 
1  11 
Type 19 
~a 
)"  "Z 
2  12 
10 
5  12 
2 
1 
7  37 
Type31 
5- 
i 
4 
13  0 
Table III.  It is noteworthy that  serological  types  14,  19,  and  26  included 
strains which produced no proteir~se and were each associated with either the 
presence or absence of rheumatic fever recurrences in susceptible subjects. 
The majority of the strains belonging to the serological types 17,  19, and 30 
which showed uniformly positive or negative proteinase activity were isolated 
during epidemics of streptococcal infections and are probably derived from com- 
mon sources.  The fact that these epidemic strains of the same serological type 
each  had  their  origin from a  single parent  strain  and  induced  a  variety of 
clinical  reactions  to  infection  emphasizes  the  lack  of  correlation  between 
the proteinase capacity of the serological type and the disease state. 
Comparison of Proteinase Capacity of Strains Isolated in Acute and Convales- 
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intervals during the acute phase of illness through convalescence was selected 
to determine whether any change in proteinase capacity occurred.  In the test 
for this activity the time at which coagulation of the milk first occurred gave a 
roughly quantitative estimate of proteinase production.  Eight serial weekly 
cultures from a patient with a type 38 infection and 12 from a patient with a 
type 26 infection showed a uniformly negative response  when tested for pro- 
teinase production; 5 weekly cultures from a patient with a type 12 infection, 8 
from a patient infected with an unclassified strain, and 6 cultures from a pa- 
tient with a type 30 infection showed positive reactions which were quantita- 
tively consistent.  In addition, from 4 to 7 weekly cultures of 3 sulfadiazine- 
resistant strains from patients with type 17 infections  were tested for consistency 
of enzyme production by cultures isolated in the acute phase through con- 
valescence.  None of these cultures produced proteinase. 
The majority  of the patients from whom  epidemic strains were obtained at the 
Hospital of the Rockefeller Institute received therapeutic doses of sulfadlazine 
for 7 to 14 days in an effort to clear up the carrier state or purulent complica- 
tions.  Cultures were taken from patients both before and after sulfadiazine 
therapy to observe any possible change in enzyme production due to the action 
of the drug.  Proteinase-positive  cultures were isolated both before and after 
therapy from 4 patients, two with type 23 infections, and one each with a type 
30 and a type 3 infection.  Proteinase-negative strains were similarly isolated 
from 6 patients, 3 with type 19 infections and 3 with infections of types 6, 14, 
and 38 respectively.  In all cases the proteinase activity remained unchanged. 
The remarkable uniformity  of proteinase production of these strainswhile they 
remained in the nasopharynx of patients suggests that the capacity to produce 
this enzyme is reasonably stable. 
Proteinase Production by Various Serological Groups and Types of Hemolytic 
Streptococci~To determine the relationship between the serological groups and 
types of hemolytic streptococci  and proteinase production, a series of strains 
were tested from multiple sources which included the strains of group A strep' 
tococci previously considered in this report.  In addition, other strains selected 
from laboratory stock cultures kept in the lyophilized  state for many years 
were included. 
A total of 238 strains, of which 208 belonged  to group A and 30 to other 
established Lancefield  groups, 2 was  assayed.  There  were  41  known  sero- 
logical types of group A streptococci represented; and 23 group A strains were 
not classified into types with the available sera.  The capacity to clot milk 
appeared to be limited to group A strains with the exception  of one group D 
strain, D76, probably bovine in origin, and one group M  strain, D168A"X", 
isolated from the vagina of a normal dog.  Both of these strains were tested in 
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duplicate and on different days; in each test, milk was clotted between 4 and 
24 hours.  The pH of the cultures was 6.8, which excludes acid clotting of the 
milk.  The possibility that some other enzyme system might also cause clotting 
of milk must be considered.  Certain group D strains, notably S. liquefa¢iens, 
are known to have proteolytic properties which may be different from the one 
studied in group A streptococci. 
Of 208  group A  strains tested,  107  or 51  per cent produced the enzyme. 
Since 23 strains could not be typed, a  total of 185 strains, distributed among 
41  different serological types of group A  streptococci, is tabulated  in Table 
IV.  Of the types represented, 35 had more than one strain and of these, ii 
types (1,  2,  3,  4,  17,  19,  24,  28,  29,  43,  and 46)  comprised both proteinase- 
positive  and  negative  strains.  The  large  number  of positive-  or  negative- 
enzyme-producing strains in types 17, 19, and 30 is due to the fact that they 
are  epidemic strains and probably originated from a  common strain of the 
corresponding type.  From these data it appears that many of the serological 
types of group A streptococci include strains capable of producing proteinase 
and others which do not produce this enzyme.  However, further studies are 
necessary before such variations can be established as characteristic of the 
type. 
Relationship  between the Presence of Proteinase and  Streptokinase  in Broth 
Cultures.--Since  Elliott  (1)  has demonstrated that  streptococcal proteinase 
digests streptokinase,  the  relationship of these enzymes in cultures was in- 
vestigated.  In  Table  V  is  shown  the  reciprocal  relationship  between  the 
presence of proteinase and the demonstration of streptokinase in cultures of 
various strains of hemolytic streptococci grown in Pfanstiehl peptone broth. 
The proteinase production was determined by both the milk-coagulation and 
azocoll tests; and the results of the measurement by these two methods were 
identical.  The pH of the filtrates varied from 5.9 to 6.3.  The reaction was 
never low enough to cause acid clotting of milk.  A  total of 37  strains of 9 
different serological types of group  A  streptococci was  tested in  Pfanstiehl 
broth.  Of these, 20 strains produced proteinase and no streptokinase, while 17 
strains were proteinase-negative and streptokinase-positive. 
In the present  study advantage was  taken of the  observations of Elliott 
and Dole  (2)  to determine whether the  reciprocal relationship between  the 
presence of proteinase and streptokinase would be maintained in both Pfanstiehl 
and neopeptone broth.  Ten strains of 5 different serological types were tested 
in both broths.  In 7 of these strains, proteinase but no streptokinase was found 
in Pfanstiehl broth, and streptokinase but no proteinase was detected in neopep- 
tone broth.  The results in the other 3 strains were variable.  It appears that 
in  strains  which  produce  both  proteinase  and  streptokinase  the  reciprocal 
relationship  between these  two  streptococcal components is,  in most cases, 
dependent on the conditions in the culture media suitable for the production of 
the inactive or active proteinase: Thus in neopeptone broth the streptococcal SIDNEY ROTHBARD  AND  EDGAR  W.  TODD  291 
TABLE IV 
Proteinase Production by Group A Streptococci of Various Serological Types 
Proteinase  production 
Serological type 
4 
5 
6 
8 
9 
11 
12 
13 
14 
15 
17 
18 
19 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
No. of strains 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
46 
47 
5 
2 
8 
3 
3 
7 
3 
2 
2 
3 
3 
5 
3 
16" 
3 
44* 
3 
3 
6 
1 
5 
1 
3 
3 
13" 
2 
3 
3 
1 
2 
3 
1 
3 
1 
3 
1 
2 
3 
3 
3 
1 
Positive 
2 
1 
5 
1 
3 
0 
3 
2 
2 
3 
3 
0 
3 
1 
0 
7 
3 
3 
5 
1 
0 
1 
2 
1 
13 
2 
0 
3 
0 
2 
3 
0 
0 
1 
3 
1 
2 
2 
3 
1 
1 
Negative 
3 
1 
3 
2 
0 
7 
0 
0 
0 
0 
0 
5 
0 
15 
3 
37 
0 
0 
I 
0 
5 
0 
1 
2 
0 
0 
3 
0 
1 
0 
0 
1 
3 
0 
0 
0 
0 
1 
0 
2 
0 
Totals ....  185  89  96 
* The majority of these cultures were epidemic strains and in each typewere probably 
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cells produce the proteinase as a precursor which is inactive and streptokinase is 
not digested; whereas in Pfanstiehl broth, the active proteinase is formed and 
the streptokinase is digested. 
DISCUSSION 
A unique opportunity was provided for obtaining epidemic strains of several 
serological types of group A streptococci from patients with a variety of clinical 
responses  to  infection.  These  strains  were  isolated  from young  adults  in 
the second decade of life who lived under similar conditions while in Naval 
TABLE V 
P~la~ionship between  t~ Presence of Proteinaa¢ and the Demonstration of Streptoldna¢# 
in Cultures of Group A  Slreptococci 
Serologicad  type 
1 
3 
6 
17 
19 
19 
24 
30 
33 
36 
Total strains.. 
1 
2 
1 
7 
5 
9 
1 
9 
1 
1 
Proteinase* 
+ 
÷ 
+ 
+ 
÷ 
+ 
+ 
Proteinase-positive  ....... 20 
Proteinase-negative  ...... 17 
Streptoklnase 
+ 
÷ 
+ 
Streptokinase-positive  ...... 17 
Streptokln~e-neptive .....  20 
Symbols -I- or -- indicate the presence or absence of proteinase or streptokinase. 
* The results of the measurement  of proteinase production by milk-coagulation  and azocoll 
titration  were identical. 
service.  Moreover, a  relatively large number of these epidemic strains were 
of a  few serological types, in each of which the capacity of the streptococci 
to  produce  proteinase  was  uniform.  The  epidemic  conditions  suggested 
common origins for the strains within each type and made possible a study of 
the effect of proteinase production upon the clinical manifestations in patients, 
uncomplicated by other differences in the streptococci. 
The data obtained revealed no evidence that proteinase or non-proteinase-- 
producing epidemic strains of various serological types were associated with 
any particular variety of infectious process.  This was indicated by the fact 
that strains of the same serological type and proteinase activity were isolated 
from patients who developed various  clinical manifestations.  On the other 
hand, strains which differed only in their ability to produce proteinase showed 
no difference in the pathologic conditions evoked in individual patients. SIDNEY ROTHBARD  AND  EDGAR  W. TODD  293 
An especially suitable series of streptococcal strains from endemic sources 
was available for comparison with the epidemic strains described above.  The 
endemic and carrier strains were derived from individuals who had had pre- 
vious attacks of rheumatic fever and from their siblings.  All of this group 
were followed constantly for several years as previously reported (8).  Since 
a study of these strains showed the same findings as those from epidemic sources, 
it appears to be a general phenomenon that there is no correlation between the 
capacity of group A streptococci to produce proteinase and the clinical reactions 
of the patients to infection with these strains. 
The possibility was considered  that strains long resident in the throats of 
patients convalescing from infection might change in their function to elabo- 
rate  this enzyme.  Rather than any change being  observed,  a  remarkable 
stability of these strains to produce a quantitatively  uniform amount of enzyme 
over long periods was demonstrated.  This stability was apparent even in the 
presence of therapeutic doses of suifadiazine administered to the patient. 
The capacity to produce proteinase appears to be related to the strain rather 
than to the serological type, as indicated by the occurrence of both enzyme- 
and  non-enzyme-producing strains  in  many  of  the  serological  types.  In 
some of the types investigated, all of the strains were similar in their ability 
to produce enzyme.  The fact that in each instance there was intermingling 
of Naval Personnel between stations in which epidemics occurred suggests that 
these strains were probably derived from a common parent strain in each type. 
To determine whether proteinase production is characteristic of individual 
types, it will be necessary to test many more strains from unrelated sources. 
In considering this relationships it is of interest that Todd (3) found proteinase 
activity in concentrated filtrates which showed no activity before concentra- 
tion.  This suggested that most strains may produce the enzyme under suitable 
conditions. 
The reciprocal relationship between the presence  of proteinase and that of 
streptokinase in streptococcal  cultures revealed a situation analogous  to that 
observed by EUiott (1) with the type-specific NI antigen of group A streptococci. 
Proteinase digests  both streptokinase and the M  protein; therefore,  the two 
latter streptococcal components are not usually found in the same cultures 
with proteinase.  Nevertheless,  it has been observed  that occasionally strep- 
tokinase may be present in small amounts simultaneously with proteinase,  a 
situation also found to hold true with regard to the balance between the presence 
of M protein and proteinase in the same system (1).  In the case of the two 
enzymes,  one of which destroys the other, presumably the streptococcal cell 
may maintain constantly its function of producing both, but the balance be- 
tween their relative concentrations is determined by the conditions prevailing 
in the culture at the time of testing. ~  PRODUCTION  OF  PROTEINASE  BY  HEMOLYTIC  STREPTOCOCCI 
SUmmARY 
The  proteinase  activity  of  strains  of  group  A  streptococci  isolated  from 
patients in acute and convalescent phases of illness was found to be remarkably 
constant.  Sulfadiazine  therapy of patients  did not affect proteinase produc- 
tion by the infecting streptococci. 
The ability to produce streptococcal proteinase would appear to be related 
to the strain and not necessarily to the serological type. 
No relationship could be found between the capacity of group A streptococci 
of  different  serological  types  to produce  proteinase  and  the  various  clinical 
responses to infection with these microorganisms. 
The authors take pleasure in acknowledging the technical assistance of Miss Grace Van- 
derhoff. 
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